263 completed, 54 recruiting, 40 unknown, 33 terminated. 122 Not applicable, 119 Phase 2, 84 Phase 3, 33 Phase 1, 29 Phase 4.
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of Age Abrocitinib, Placebo - Atopic Dermatitis | Phase 3 | Not yet recruiting | Pfizer | 90 | 2027-05-01 | 2026-09-16 |
| Educational Eczema Video Intervention in-clinic video intervention, at home video intervention - Eczema | Not applicable | Withdrawn | Boston Children's Hospital | 2027-01-01 | 2026-10-19 | |
| Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis Digital App Mindfulness Meditation, Mindfulness Meditation Sheet - Atopic Dermatitis, Eczema | Not applicable | Recruiting | Weill Medical College of Cornell University | 40 | 2026-11-15 | 2026-10-23 |
| Evidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring Vibroacoustic sensing device - Eczema, Psoriasis | Not yet recruiting | University of Edinburgh | 20 | 2026-10-01 | 2026-09-29 | |
| Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin Diseases Psoriasis, Eczema/Atopic Dermatitis | Not yet recruiting | Medisch Spectrum Twente | 1000 | 2026-10-01 | 2026-09-04 | |
| Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic Dermatitis Retention of Vernix Caseosa After Birth, Removal of Vernix Caseosa After Birth - Atopic Dermatitis | Not applicable | Recruiting | Pontificia Universidad Catolica de Chile | 1383 | 2026-09-29 | 2026-09-30 |
| A Randomised Controlled Trial of ePROM-Guided Flexible Scheduling in Dermatology Flexible ePROM-guided Scheduling System, electronic patient reported outcome measures (ePROMs) - Chronic Dermatological Conditions, Eczema | Not applicable | Not yet recruiting | National University Hospital, Singapore | 250 | 2026-09-01 | 2026-07-01 |
| Multi-Omic SignAtures of Inflammatory Cutaneous Diseases Inflammatory Skin Conditions | Not yet recruiting | Guy's and St Thomas' NHS Foundation Trust | 400 | 2026-09-01 | 2026-08-18 | |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema Tilrekimig, Dupilumab, Placebo for Tilrekimig - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 1375 | 2026-08-24 | 2026-10-22 |
| A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema Tilrekimig, Placebo - Atopic Dermatitis | Phase 3 | Recruiting | Pfizer | 375 | 2026-08-17 | 2026-10-15 |
| The Impact of Dietary Salt on the Severity of Eczema Sodium chloride tablets, Placebo Tablets - Eczema, Atopic Dermatitis | Phase 4 | Recruiting | University of California, San Francisco | 40 | 2026-08-10 | 2026-09-10 |
| Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream. Roflumilast Cream 0.15% - ITCH, Atopic Dermatitis | Phase 4 | Recruiting | Integrative Skin Science and Research | 40 | 2026-07-21 | 2026-08-13 |
| The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease Sodium chloride tablets, Placebo Tablets - Atopic Dermatitis (Eczema), Psoriasis | Phase 4 | Recruiting | University of California, San Francisco | 50 | 2026-07-14 | 2026-09-09 |
| A Clinical Trial to Evaluate the Effects of Rejuvaskin Eczema Body Wash and Skin Recovery Cream in Adults With Eczema-Prone Skin Rejuvaskin Eczema Body Wash - Eczema, Atopic Dermatitis | Not applicable | Active not recruiting | Rejuvaskin | 35 | 2026-07-06 | 2026-07-14 |
| Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under Nemolizumab Atopic Dermatitis (AD), Atopic Dermatitis (Eczema) | Recruiting | Hôpitaux Drôme Nord | 15 | 2026-06-11 | 2026-07-28 | |
| Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis IMG-007 - Atopic Dermatitis, Atopic Dermatitis Eczema | Phase 2 | Enrolling by invitation | Inmagene LLC | 400 | 2026-06-05 | 2026-07-29 |
| Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares Nevisense electrical impedance spectroscopy - Atopic Dermatitis | Recruiting | Castle Biosciences Incorporated | 450 | 2026-06-04 | 2026-10-20 | |
| A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic Dermatitis DCY636, Placebo - Dermatitis, Atopic | Phase 1 | Recruiting | Novartis Pharmaceuticals | 63 | 2026-06-02 | 2026-08-19 |
| Improved Child Nutrition and Development Through Social Transfers Social Transfer - Breastfeeding, Breastfeeding Education | Not applicable | Not yet recruiting | Swiss Tropical & Public Health Institute | 1040 | 2026-06-01 | 2026-05-06 |
| A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis Camoteskimab, Placebo - Atopic Dermatitis, Atopic | Phase 2 | Recruiting | Apollo Therapeutics Ltd | 280 | 2026-05-28 | 2026-08-28 |
Showing 20 of 454. Sign in to see all of them.
Dermatitis, Atopic (324) · Dermatitis (79) · Skin Diseases (52) · Pruritus (44) · Hypersensitivity (33) · Psoriasis (31) · Asthma (26) · Immune System Diseases (19) · Skin Diseases, Eczematous (17) · Food Hypersensitivity (16) · Skin Diseases, Genetic (15) · Acne Vulgaris (9) · Hypersensitivity, Immediate (9) · Genetic Diseases, Inborn (8)
Skin and Connective Tissue Diseases (454) · Skin Diseases, Eczematous (437) · Skin Diseases (402) · Dermatitis (375) · Immune System Diseases (351) · Hypersensitivity, Immediate (346) · Hypersensitivity (334) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (328) · Genetic Diseases, Inborn (320) · Skin Diseases, Genetic (311) · Pathological Conditions, Signs and Symptoms (70) · Signs and Symptoms (61) · Skin Manifestations (44) · Respiratory Tract Diseases (34) · Skin Diseases, Papulosquamous (32)
dupilumab (19) · abrocitinib (15) · lebrikizumab (15) · baricitinib (9) · Adrenal Cortex Hormones (6) · pimecrolimus (6) · Blood Specimen Collection (4) · Exercise (4) · gusacitinib (4) · Betamethasone (3) · Ointments (3) · Petrolatum (3) · Probiotics (3) · R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol (3) · Triamcinolone (3)
Pfizer (25) · Eli Lilly and Company (22) · Regeneron Pharmaceuticals (11) · Incyte Corporation (10) · National Institute of Allergy and Infectious Diseases (NIAID) (9) · Novartis Pharmaceuticals (8) · University of California, San Francisco (7) · Organon and Co (6) · Almirall, S.A. (5) · Amgen (5) · National University Hospital, Singapore (5) · Asana BioSciences (4) · Bayer (4) · Codex Labs Corporation (4) · GlaxoSmithKline (4)
United States (234) · Canada (94) · Germany (67) · Poland (66) · Spain (42) · United Kingdom (42) · Japan (39) · Australia (38) · Czechia (33) · France (29) · China (26) · Hungary (25) · Taiwan (22) · Italy (21) · Bulgaria (20)
David Zammit, Ph.D. (4) · Diana Villalobos (4) · Eric Simpson, MD (3) · Lisa Beck, MD (3) · Amisha Parikh-Das, PhD (2) · Arine M Vlieger, MD, PhD (2)
PMID 33826132, PMID 42162528, PMID 34406619, PMID 36255569, PMID 39588375, PMID 36749121, PMID 38896380, PMID 39104653, PMID 40028832, PMID 33982267, PMID 34275122, PMID 34688290, PMID 35342978, PMID 35567671, PMID 38777187, PMID 40383273, PMID 40600584, PMID 40993471, PMID 41206702, PMID 42365219, PMID 31595499, PMID 33222559, PMID 33481203, PMID 33658996, PMID 33899152, PMID 33954933, PMID 33957195, PMID 34270797, PMID 34427891, PMID 34743361, PMID 35061234, PMID 35462428, PMID 35763326, PMID 36184023, PMID 36264430, PMID 36723913, PMID 36920778, PMID 36994947, PMID 37750994, PMID 37949351, PMID 37988255, PMID 38679419, PMID 38698175, PMID 38700646, PMID 38743155, PMID 38922484, PMID 39002092, PMID 39123054, PMID 39249591, PMID 39375281
2018 (12), 2023 (10), 2019 (8), 2017 (5), 2025 (3), 2015 (2), 2016 (2), R21AR062357 (2), 2008 (1), 2014 (1), K24HD069408 (1), R01AR071057 (1), R01AR073486 (1), R01AR082831 (1), R01HD050758 (1)